Navigation Links
Veridex Completes Acquisition of Immunicon Corporation Assets

RARITAN, N.J., Aug. 1 /PRNewswire/ -- Veridex, LLC announced today it has completed its previously announced acquisition of substantially all of the assets of Immunicon Corporation (OTC Bulletin Board: IMMC) and its wholly-owned subsidiaries.

The assets acquired include intellectual property, product inventory and clinical data as well as all technologies related to the CellSearch(TM) System, the first diagnostic test to automate the detection and enumeration of circulating tumor cells (CTCs), cancer cells that detach from solid tumors and enter the blood stream. The CellSearch(TM) System is currently cleared for the prognosis and monitoring of patients with metastatic breast, metastatic colorectal and metastatic prostate cancer. As part of the agreement, Veridex also received all technologies related to Repeat-Free(TM) (RF) Poseidon(TM) Fluorescent In-Situ Hybridization (FISH) Probes, which are the latest advance in FISH DNA probes.

"This asset purchase ensures the role of CellSearch(TM) in the future of Veridex," said Ken Berlin, General Manager, Veridex, LLC. "It underscores our continued commitment to the medical community and to cancer patients who may benefit from technologies like the CellSearch(TM) System."

Veridex and Immunicon have partnered since 2000 to develop and commercialize novel cancer diagnostic platforms and products.

About Veridex

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes. For more information, please visit

Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
2. Emisstar Completes 2-Year Emission Control Technology Showcase
3. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
4. iCAD Completes Acquisition of CAD Sciences
5. Vertos Medical Inc. Completes Series C Financing
6. Houston-Based Tyrell, Inc. Completes $28 Million Private Equity Financing
7. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
8. Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs
9. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
10. USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
11. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: